Uniunea Europeană - română - EMA (European Medicines Agency)

novartis europharm limited - vildagliptin - diabetul zaharat, tip 2 - medicamente utilizate în diabet - vildagliptin is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:as monotherapy in patients in whom metformin is inappropriate due to contraindications or intolerance. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 și 5. 1 pentru datele disponibile pe diferite combinații).

România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

meduman s.a. - romania - barii sulfas - pulb. pt. susp. orala - 500mg/ml - medii de contrast pt. radiologie, fara iod medii de contrast pt. radiologie cu sulfat de ba

România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

arena group s.a. - romania - fluconazolum - compr. - 10mg - propulsive propulsive

România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

arena group s.a. - romania - paracetamolum - compr. - 500mg - alte analgezice si antipiretice anilide (inclusiv combinatii)

România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

meduman s.a. - romania - naphazolinum - pic. nazale, sol. - 1mg/ml - decongestionante si alte medicamente nazale de uz topic simpatomimetice

România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

meduman s.a. - romania - chlorquinaldolum - pulb. cut. - 30mg/g - antiseptice si dezinfectante derivati de chinolone

România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

arena group s.a. - romania - atenololum - compr. - 50mg - medicamente betablocante betablocante selective

România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

meduman s.a. - romania - combinatii - pic. bucofaringiene sol. - 2,425mg/21,34mg/ml - medicamente pentru cavitatea bucala alte medicamente pt. tratamentul local al cavitatii bucale

Uniunea Europeană - română - EMA (European Medicines Agency)

mylan ireland limited - sitagliptin hydrochloride monohydrate, metformin hydrochloride - diabetul zaharat, tip 2 - medicamente utilizate în diabet - for adult patients with type 2 diabetes mellitus:sitagliptin/metformin hydrochloride mylan is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. sitagliptin/metformin hydrochloride mylan is indicated in combination with a sulphonylurea (i. , terapie triplă) ca adjuvant la dietă și exercițiu fizic, la pacienți controlați inadecvat cu doza maximă tolerată de metformin și o sulfoniluree. sitagliptin/metformin hydrochloride mylan is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparg) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparg agonist. sitagliptin/metformin hydrochloride mylan is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.

Uniunea Europeană - română - EMA (European Medicines Agency)

accord healthcare s.l.u. - metformin hydrochloride, vildagliptin - diabetul zaharat, tip 2 - medicamente utilizate în diabet - vildagliptin/metformin hydrochloride accord is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:- in patients who are inadequately controlled with metformin hydrochloride alone. - in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. - in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 și 5. 1 pentru datele disponibile pe diferite combinații).